Conformal radiation therapy with or without intensity modulation in the treatment of localized prostate cancer;La radiothérapie de conformation avec et sans modulation d'intensité dans le traitement du cancer localisé de la prostate

Cancer/Radiotherapie

Volumn 9, Issue 6-7, 2005, Pages 382-387

  Maingon, P ^a   Bolla, M ^b   Truc, G ^a   Bosset, M ^a   Peignaux, K ^a   Ammor, A ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Conformal radiation therapy; Intensity modulated radiation therapy; Prostate cancer; Radiation therapy

Indexed keywords

ADVANCED CANCER; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; DOSE CALCULATION; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; REPRODUCIBILITY; REVIEW; TREATMENT PLANNING;

EID: 28344455506     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.06.006     Document Type: Short Survey

References (31)

1. X. Artignan, M.H. Smitsmans, J.V. Lebesque, D.A. Jaffray, M. Van Herk, and H. Bartelink Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement Int. J. Radiat. Oncol. Biol. Phys. 59 2004 595 601
2. D. Boehmer, J. Bohsung, I. Eichwurel, A. Moys, and V. Budach Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer Radiother. Oncol. 71 2004 319 325
3. M. Bolla, D. Gonzalez, P. Warde, J.B. Dubois, R.O. Mirimanoff, and G. Storme Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and Gozeroline N. Engl. Med. 337 1997 295 300
4. A.V. D'Amico, J. Manola, M. Loffredo, L. Lopes, K. Nissen, and D.A. O'Farrell A practical method to achieve prostate gland immobilization and target verification for daily treatment Int. J. Radiat. Oncol. Biol. Phys. 51 2001 1431 1436
5. A.V. D'Amico, R. Whittington, I. Kaplan, C. Beard, D. Schultz, and S.B. Malkowicz Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV Int. J. Radiat. Oncol. Biol. Phys. 39 1997 335 340
6. D.P. Dearnaley, E. Hall, D. Lawrence, R.A. Huddart, R. Eeles, and C.M. Nutting Phase III pilot study of dose-escalation using conformal radiotherapy in prostate cancer: PSA control and side effect Br. J. Cancer 92 2005 488 498
7. D.P. Dearnaley, V.S. Khoo, A.R. Norman, L. Meyer, A. Nahum, and D. Tait Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial Lancet 353 1999 267 272
8. C. Fiorino, G. Sanguineti, C. Cozzarini, G. Fellin, F. Foppiano, and L. Menegotti Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 57 2003 953 962
9. G.E. Hanks, K.L. Martz, and J.J. Diamond The effect of dose on local control of prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 15 1988 1299 1306
10. M.S. Hoogeman, M. Van Herk, J. de Bois, and J.V. Lebesque Strategy to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer Radiother. Oncol. 74 2005 177 185
11. R. Jacob, A.L. Hanlon, A.M. Horwitz, B. Movsas, R.G. Uzzo, and A. Pollack Role of prostate dose-escalation in patients with greater than 15% risk of pelvic lymph-node involvement Int. J. Radiat. Oncol. Biol. Phys. 61 2005 695 701
12. L. Kestin, N. Goldstein, F. Vicini, D. Yan, H. Korman, and A. Martinez Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int. J. Radiat. Oncol. Biol. Phys. 54 2002 686 697
13. J. Lattanzi, S. McNeeley, A. Hanlon, T.E. Schultheiss, and G.E. Hanks Ultra-sound based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer Urology 55 2000 73 78
14. P.W. McLaughin, V. Narayana, A. Meirovitz, S. Troyer, P.L. Roberson, and R. Gonda Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI Int. J. Radiat. Oncol. Biol. Phys. 61 2005 20 31
15. X.A. Li, J.Z. Wang, P.A. Jursinic, C.A. Lawton, and D. Wang Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 61 2005 1251 1257
16. R. Miralbell, D. Taussky, O. Rinaldi, A. Lomax, S. Canales, and L. Escude Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild to moderate late rectal toxicity Int. J. Radiat. Oncol. Biol. Phys. 57 2003 1280 1284
17. D.E. Morris, B. Emami, P.M. Mauch, A.A. Konski, M.L. Tao, and A.K. Ng Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative Int. J. Radiat. Oncol. Biol. Phys. 62 2005 3 19
18. S.T.H. Peeters, W.D. Heemsbergen, W.L.J. Van Putten, A. Slot, H. Tabak, and J.W. Mens Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 to 78:Gy Int. J. Radiat. Oncol. Biol. Phys. 61 2005 1019 1034
19. A. Pollack, G.K. Zagars, L.G. Smith, J.J. Lee, A.C. Von Eschenbach, and J.A. Antolak Preliminary results of a randomized radiotherapy dose-escalation study comparing 70:Gy with 78:Gy for prostate cancer J. Clin. Oncol. 18 2000 3904 3911
20. M. Roach, M. DeSilvio, C. Lawson, V. Uhl, M. Machtay, and M.J. Seider Phase III trial comparing whole-pelvic vs prostate-only radiotherapy and neo-adjuvant vs adjuvant combined androgen suppression: Radiation therapy oncology group 9413 J. Clin. Oncol. 21 2003 1904 1911
21. M. Roach, K. Winter, J.M. Michalsky, J.D. Cox, J.A. Purdy, and W. Bosch Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective multi-institutional phases I/II dose-escalation study Int. J. Raidat. Oncol. Biol. Phys. 60 2004 1351 1356
22. U. Selek, R. Cheung, M. Lii, P. Allen, R.E. Steadham, and T.R. Vantreese Erectile dysfunction and radiation-dose to the penile base structures: a lack of correlation Int. J. Radiat. Oncol. Biol. Phys. 59 2004 1039 1046
23. C.F. Serago, S.J. Chungbin, S.J. Buskirk, G.A. Ezzell, A.C. Collie, and S.A. Vora Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 53 2002 1130 1138
24. J.C. Stroom, P.C. Koper, G.A. Korevaar, M. Van Os, M. Janssen, and H.C. De Boer Internal organ motion in prostate cancer patients treated in prone and supine position Radiother. Oncol. 51 1999 237 248
25. B.S. Teh, M.D. Bastasch, W.Y. May, E.B. Butler, and T.M. Wheeler Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy and surgery Cancer 9 2003 454 460
26. G.M. Villeirs, G.O. de Meerleer, K.L. Verstraete, and W.J. De Neve Magnetic resonance localization variability in intensity-modulated radiotherapy for prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 60 2004 1611 1621
27. T.M. Wheeler, O. Dillioglugil, M.W. Kattan, A. Arakawa, S. Soh, and K. Suyama Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer Hum. Pathol. 29 1998 856 862
28. J. Wu, T. Haycocks, H. Alasti, G. Ottewell, N. Middlemiss, and M. Abdolell Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers Radiother. Oncol. 61 2001 127 134
29. S. Yu-Ming Liu Ling, K.M. Langen, K. Shinohara, V. Weinberg, J. Pouliot, and M.I.I.I. Roach Prostate movement during simulation resulting from retrograde urethrogramm compared with 'natural' prostate movement Int. J. Radiat. Oncol. Biol. Phys. 60 2004 470 475
30. M.J. Zelefsky, Z. Fuks, M. Hunt, H.J. Lee, D. Lombardi, and C.C. Ling High-dose radiation delivered by intensity-modulated conformal radiotherapy improves the outcome of localized prostate cancer J. Urol. 166 2001 876 881
31. M.J. Zelefsky, L. Happersett, S.A. Leibel, C.M. Burman, L. Schwartz, and A.P. Dicker The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 37 1997 13 19